Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 9/20 | 0.36 |
| ▸ | CNR2 | P34972 | 7/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GPR6 | P46095 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.33 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22430730 | 1.00 | GPR55 (0.52) | GPR55MEN1MAPTKMT2ACNR1 | |
| SCHEMBL22705363 | 0.92 | GPR55 (0.46) | GPR55MEN1MAPTKMT2ACNR1 | |
| SCHEMBL31545325 | 0.92 | GPR55 (0.46) | GPR55MEN1MAPTKMT2ACNR1 | |
| SCHEMBL23587275 | 0.84 | GPR55 (0.41) | GPR55MEN1MAPTKMT2ACNR1 | |
| SCHEMBL24689712 | 0.82 | GPR55 (0.39) | GPR55MEN1MAPTKMT2ACNR1 | |
| SCHEMBL22537449 | 0.81 | CNR1 (0.49) | GPR55MEN1KMT2ACNR1CNR2 | |
| SCHEMBL18386358 | 0.81 | CNR1 (0.49) | GPR55MEN1KMT2ACNR1CNR2 | |
| SCHEMBL23587175 | 0.81 | GPR55 (0.39) | GPR55MEN1MAPTKMT2ACNR1 | |
| SCHEMBL24525885 | 0.79 | CNR1 (0.37) | GPR55CNR1CNR2OPRM1TRPA1 | |
| SCHEMBL21921970 | 0.78 | GPR55 (0.36) | GPR55CNR1CNR2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11344527-B2 | Methods and compositions for treating cancer | SUTTER BAY HOSPITALS (US) | 2022-05-31 | — | — | US | disclosed |
| WO-2021211915-A1 | POLYCANNABINOIDS, COMPOUNDS, COMPOSITIONS AND METHODS OF USE | UNIVERSITY OF CONNECTICUT (US) | 2021-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11344527-B2 | Methods and compositions for treating cancer | CNR2, CNR1, JUP | GPR55 597/4885MEN1 1755/4885MAPT 1395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.